Related Experiment Video

Updated: Aug 11, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

[Platelet function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 2.

M Marshall

    Fortschritte Der Medizin
    |May 13, 1982
    PubMed

    Insights

    Preventing arterial occlusive disease involves eliminating risk factors. Antiplatelet drugs are beneficial for secondary prevention in myocardial infarction, carotid artery stenosis, and peripheral arterial disease, with specific uses in vascular surgery.

    Area of Science:

    • Cardiovascular Medicine
    • Vascular Surgery
    • Pharmacology

    Context:

    • Arterial occlusive diseases represent a significant health burden, necessitating effective prevention and treatment strategies.
    • Risk factor modification is key for primary prevention, while secondary prevention focuses on managing established conditions.
    • Pharmacological interventions, including antiplatelet agents and anticoagulants, play crucial roles in managing arterial diseases.

    Purpose:

    • To review the current evidence and indications for antiplatelet drugs and anticoagulation in the prevention and treatment of arterial occlusive diseases.
    • To differentiate the therapeutic roles of antiplatelet therapy versus anticoagulation in various clinical scenarios.
    • To provide guidance on the optimal use of these agents in secondary prevention, asymptomatic disease, and post-procedural prophylaxis.

    Summary:

    • Antiplatelet drugs are effective in secondary prevention of myocardial infarction, treatment of asymptomatic carotid stenosis (particularly in males), and long-term management of peripheral arterial disease.
    • Anticoagulation may be beneficial for limited periods and is preferred for severe stenoses in critical locations and after bypass surgery.
    • Antiplatelet therapy is superior for pre- and after-treatment of percutaneous catheter recanalization and indicated after endarteriectomy in vascular surgery.

    Impact:

    • This review clarifies the differential indications for antiplatelet drugs and anticoagulation, optimizing therapeutic strategies for various arterial occlusive conditions.
    • Improved understanding can lead to more targeted and effective prevention of thrombotic events and improved patient outcomes.
    • The findings support evidence-based decision-making in the management of patients with or at risk of arterial occlusive diseases.

    More Related Videos

    Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

    Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

    Published on: March 15, 2022

    Microfluidics in Assessing Platelet Function06:47

    Microfluidics in Assessing Platelet Function

    Published on: November 8, 2024

    Related Concept Videos

    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Peripheral Artery Disease I: Introduction01:30

    Peripheral Artery Disease I: Introduction

    Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
    Peripheral Artery Disease III: Interprofessional Care01:27

    Peripheral Artery Disease III: Interprofessional Care

    Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
    Venous Thrombosis III: Interprofessional Care01:29

    Venous Thrombosis III: Interprofessional Care

    Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...